Fellowship

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Search
Generic filters
Search
Generic filters

Name

Position

Level

Elected

State

Director, Centre for Research in Evidence-Based Practice
Bond University
Fellow
2015
QLD

Paul Glasziou FRACGP, PhD is Professor of Evidence-Based Medicine at Bond University and a part-time General Practitioner. He was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice, reducing waste in research, and preventing overdiagnosis. He is the author of seven books related to evidence based practice: Systematic Reviews in Health Care, Decision Making in Health Care and Medicine: integrating evidence and values, An Evidence-Based Medicine Workbook, Clinical Thinking: Evidence, Communication and Decision-making, Evidence-Based Medicine: How to Practice and Teach EBM, and Evidence-Based Medical Monitoring: Principles and Practice, and Testing Treatments. He has authored over 250 peer-reviewed journal articles. He is the recipient of an NHRMC Australia Fellowship which he commenced at Bond University in July, 2010.

 

 

Emeritus Professor
QIMR Berghofer Medical Research Institute
Fellow
2015
QLD

Professor Frank Gannon is an international thought leader and researcher. His contributions have been recognised by election to EMBO, Acadamiae Europaeae, Royal Irish Academy, European Academy of Cancer Sciences, Mexican Academy of Medicine and Honorary doctorates from three universities. He leads a major medical research Institute active in discovery and translational research. His research has ranged from the isolation of one of the first eukaryote genes to the provision of new insights on the control of gene expression, based on studies of the estrogen receptor. He has also contributed over 100 editorials on topics of relevance to science and society.

AC FRS FAA FTSE FAHMS
Chair, Foundation Board
Translational Research Institute, University of Queensland
Fellow
2014
QLD

Professor Ian Frazer works to raise awareness and funds for medical research through his role with The University of Queensland (UQ) and as Chair of the TRI Foundation Board.  He is also the current Chair of the advisory board advising the commonwealth government on the use of the Medical Research Future Fund, a member of the Commonwealth Science Council and President of the Australian Academy of Health and Medical Science.

At UQ, Professor Frazer works with the Deputy Vice-Chancellor (Research) as an advisor on medical research and with the Vice-Chancellor on fundraising through the University’s Campaign Committee.  He also leads a research program at TRI on skin cancer immunology with staff from UQ’s Diamantina Institute and continues to work with Admedus Vaccines on a herpes vaccine and new vaccine technologies.

As the founding Chief Executive Officer and Director of Research for the Translational Research Institute (TRI) in Brisbane, Australia, Professor Frazer lead the development of a world-leading biomedical research facility focused on translating scientific knowledge into practical benefits for the community.  Combing the intellect of its partners: the University of Queensland’s Diamantina Institute, Mater Research and School of Medicine; Queensland University of Technology Institute of Health and Biomedical Innovation; and the Princess Alexandra Hospital Centres for Research, with a Clinical Research Facility and a co-located biopharmaceutical manufacturer, TRI has the capacity to discover, produce, test and manufacture new treatments and vaccines in one location.

Internationally renowned for the co-creation of the technology for the cervical cancer vaccines, Professor Frazer began his career as a renal physician and clinical immunologist in Edinburgh, Scotland before emigrating in 1981 to Melbourne, Australia. He continued his clinical training and pursued studies in viral immunology and autoimmunity at the Walter and Eliza Hall Institute of Medical Research with Professor Ian Mackay. In 1985, Professor Frazer accepted a teaching post with the University of Queensland and was appointed Director of The University of Queensland Diamantina Institute in 1991. In early 2011, Professor Frazer relinquished directorship of the Institute to commence as CEO and Director of Research for TRI. In February 2015, he relinquished this role to focus more on his research.

Professor Frazer was awarded the 2005 CSIRO Eureka Prize for Leadership in Science and was selected as Queenslander of the Year, and Australian of the Year in 2006. He was also awarded the 2008 Prime Minister’s Prize for Science, the 2008 Balzan Prize for Preventive Medicine, the 2009 Honda Prize and was recently elected as a Fellow of the esteemed Royal Society of London. In 2012, Professor Frazer was appointed a Companion of the Order of Australia (AC) in the Queen’s Birthday Honours. In 2014, Professor Frazer was elected as the inaugural President of the Australian Academy of Health and Medical Sciences.

 

FAA FTSE FAHMS
Emeritus Professor
John Curtin School of Medical Research, Australian National University
Council Member
2014
ACT

Professor Simon Foote was appointed as Director of the John Curtin School of Medical Research at the Australian National University in November 2014. His prime research interests are in the areas of infectious disease, specifically malaria, where his team is developing new antimalarials using a genetics approach. He has worked on the genetics of numerous diseases including Multiple Sclerosis and Cancer and leads a team who are trying to understand the genetics of indigenous glomerulonephropathy.

Professor Foote obtained his medical degree in 1984 at the University of Melbourne and in 1989 completed his PhD in Molecular Genetics studying the genetic basis of drug resistance of the malarial parasite. He worked at the Genome Center at the Whitehead Institute, Massachusetts Institute of Technology where he produced the first physical map of a human chromosome and then a map of the entire human genome. He returned to Australia where he headed the Genetics and Bioinformatics Division at the Walter & Eliza Hall Institute of Medical Research, Melbourne, was the Director of the Menzies Research Institute Tasmania, University of Tasmania from 2005 to 2011, and the Dean of the Australian School of Advanced Medicine at Macquarie University from 2012 – 2014.

Deputy Vice Chancellor (Research)
The University of New South Wales
Fellow
2015
NSW

Professor Fisk has a sustained record of clinical innovation as an obstetrician/fetal medicine specialist. He has pioneered significant advances in understanding fetoplacental disease and its treatment including characterising early human fetal stem cell populations, documenting “fetal pain” and its blockade by opioid analgesia, and unravelling the vascular basis of twin-to-twin transfusion syndrome. Professor Fisk has a longstanding record of leadership advancing the health and medical profession, and is strongly committed to community outreach and engagement. In a professorial career spanning more than 20 years, Professor Fisk has lectured widely in clinical education fora and advocated strongly for national/state guideline development.

AC FAA FTSE FAHMS
Special Adviser to the Australian Government on Low Emissions Technology; Chair, Technology Investment Advisory Council
Department of Industry, Science, Energy and Resources
Fellow
2015
ACT

As Chancellor of Monash University and President of ATSE, Professor Alan Finkel actively promotes education and research in the broadest sense including the substantial medical research endeavour at the University. As a research neuroscientist then businessman Alan developed advanced voltage clamp, patch clamp, data acquisition and imaging systems that contributed to the worldwide benefits from cellular electrophysiology and drug discovery, and medical devices for monitoring and treatment of Parkinson’s Disease. Alan is the founder of the Australian Course in Advanced Neuroscience, a former Board Member of the Florey Neuroscience Institutes and the Burnett Institute and a philanthropic donor to medical research.

Professor of Critical Care Medicine
The George Institute for Global Health and The University of Sydney
Fellow
2015
NSW

Professor Simon Finfer is recognised internationally for excellence as an innovative, researcher, educator, mentor and editor. He was a founding member of the ANZICS Clinical Trials Group; Chair from 2000 – 2004. He led research that has changed clinical practice around the world. He is a Guest Editor for The New England Journal of Medicine; Editor, Oxford Textbook of Critical Care; Critical Care Section Editor for The Oxford Textbook of Medicine (6th Ed.). He has established and direct The Australian Sepsis Network and have a global role in sepsis research through the Councils of the International Sepsis Forum and Global Sepsis Alliance.

Director, Clinical Translation and Advanced Education
Garvan Institute of Medical Research
Fellow
2015
NSW

Professor Eisman’s major contributions include the first clinical assay of active vitamin D, importance of vitamin D in cancer, then strong genetic determination of bone mass, identification of the first candidate gene and role in international osteoporosis GWAS. He demonstrated the importance of all fragility fractures in men and women, their relationship to premature death and treatment benefit on survival. He has established international consortia for better translation to health care. Recently he was awarded the senior, William F Neuman award of the American Society for Bone and Mineral Research and is President-elect of the International Bone and Mineral Society.

AO FASSA FAHMS
Associate Dean Indigenous; Rowden-White Chair
The University of Melbourne
Fellow
2014
VIC

Professor Sandra Eades is Domain Head Aboriginal Health and Disadvantaged Communities at Baker IDI Heart and Diabetes Institute with key expertise in Indigenous child and adolescent health, Indigenous tobacco use and randomized controlled trials in Indigenous health. The Aboriginal Health Domain incorporates a national program of research and related activities with hubs in Melbourne, Alice Springs and Sydney. Professor Eades is a medical epidemiologist and completed her undergraduate medical training at the University of Newcastle and her PhD in epidemiology at the University of Western Australia through the Telethon Kids Institute. Professor Eades has previous research appointments with the Menzies School of Health Research and the Sax Institute in Sydney.

Professor Eades awards include in 2011 Centenary of International Women’s day – listed as one of 100 Aboriginal and Torres Strait Islander women who have achieved change in their communities by National Aboriginal and Torres Strait Islander Women’s Alliance; 2006 New South Wales Woman of the Year – International Women’s Day; 2003 Bulletin Magazine Smart 100 – Named at one of 10 Health section finalists.

Director, Health Program
Grattan Institute
Fellow
2015
VIC

Dr Stephen Duckett has made an exceptional contribution to health services research and health care delivery in Australia. He has held senior health care leadership positions in Australia and Canada, with a reputation for creativity, evidence-based innovation and reform in areas as diverse as hospital funding (introduction of activity-based funding for hospitals) and quality (new systems of measurement and accountability for safety of hospital care). Dr Duckett was responsible for the design and implementation of the first application of activity based funding of hospitals in Australia, in Victoria in 1993. Activity based funding as adopted nationally in 2010. This Victorian work provided the basis fo his international reputation.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants. 

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community
      •  

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the Secretariat for application forms and further instructions on how to submit the completed nomination documentation. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the Secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2021
Newly elected Fellows of 2021 are inducted at the AGM/Scientific Meeting.

October 2021-November 2021
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2021
Nominations allocated to Selection Committees.

January – April 2022
Referees’ reports sought.

Early May 2022
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-Mid-July 2022
Council meets to finalise recommendations.

Late July 2022
Full Fellowship invited to comment on recommended new fellows.

Early August 2022
Newly elected Fellows are informed of their successful appointment.

October 2022
Newly elected Fellows of 2022 inducted at the AGM/Scientific Meeting.

Find out more

Whether you’re looking to nominate a colleague for an award, make a donation to the Academy or simply find out more about the work we do, research we advance and health policy advice we provide, sign up to our mailing list today.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.